Advertisement

Ads Placeholder
Loading...

PharmChem, Inc.

PCHM•PNK
Healthcare
Medical - Diagnostics & Research
$3.75
$0.010(0.27%)
U.S. Market opens in 57h 52m

PharmChem, Inc. (PCHM) Stock Overview

Explore PharmChem, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap22M
P/E Ratio30.42
EPS (TTM)$-212.50
ROE0.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.11

PCHM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PharmChem, Inc. (PCHM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $4.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.42 and a market capitalization of 22M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.27%
3-Month Change
1.08%
6-Month Change
19.05%
Year-to-Date (YTD) Change
20.97%
1-Year Change
11.28%
3-Year Change
38.89%
5-Year Change
29.31%
All-Time (Max) Change
-60.02%

Contact Information

https://www.pharmchek.com
855-458-4100
2411 East Loop 820 North, Fort Worth, TX, 76118

Company Facts

90 Employees
IPO DateJan 8, 2021
CountryUS

Frequently Asked Questions